Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
Dr. Quinton Fivelman Ph.D., the Chief Scientific Officer at London Medical Laboratory, is warning that thyroid problems may be escalating rapidly in the UK population and it is likely that there is a direct link between SARS-CoV-2 and abnormal thyroid function. While the average global incidence of thyroid problems in the population is only around …
“Being exposed to the SARS-CoV-2 virus doesn’t always result in infection, and we’ve been keen to understand why. We found that high levels of pre-existing T cells, created by the body [the immune system] when infected with other human coronaviruses like the common cold, can protect against COVID-19 infection….” A new study, published in Nature …
Study shows health plans paid most of the cost of ivermectin, despite the drug’s lack of official approval for use against COVID-19. Doctors continue to prescribe ivermectin – and a new study suggests health insurers are heavily subsidizing the cost of those prescriptions. The study’s authors call for insurers to align their coverage of the …
The FDA has issued an alert on September 17, 2021, regarding the potential for false-positive COVID-19 testing results using certain kits manufactured by Abbott Molecular Inc. Letter to Clinical Laboratory Staff and Health Care Providers: The U.S. Food and Drug Administration (FDA) is alerting clinical laboratory staff and health care providers of the potential for …
The FDA has revised the EUA to authorize bamlanivimab and etesevimab monoclonal antibody therapy when administered together for post-exposure prevention in certain individuals who are at high risk for severe infection or death; people should consult with their healthcare provider to find out if this post-exposure therapy is appropriate for them. A monoclonal antibody is …
In COVID-19 patients whose symptoms were mild, Stanford researchers found that they were more likely than sicker patients to have signs of prior infection by similar, less virulent coronaviruses. A study by Stanford University School of Medicine investigators hints that people with COVID-19 may experience milder symptoms if certain cells of their immune systems “remember” …
One year after infection by SARS-CoV-2, most people maintain anti-Spike antibodies regardless of the severity of their symptoms, according to a study with healthcare workers co-led by the Barcelona Institute for Global Health (ISGlobal), the Catalan Health Institute (ICS), and the Jordi Gol Institute (IDIAP JG), with the collaboration of the Daniel Bravo Andreu Private …
In combination with widespread socioeconomic distress, civil unrest, and political destabilization, yet another wave of COVID-19 is weighing down the already overwhelming burden of the ongoing pandemic on public health. Not only has the viral outbreak taken a tremendous toll on the global healthcare system and physical wellbeing of millions across the globe, but it …
U.S. life expectancy decreased by 1.87 years between 2018 and 2020, a drop not seen since World War II, according to new research from Virginia Commonwealth University, the University of Colorado Boulder and the Urban Institute. The numbers are even worse for people of color. On average, whereas life expectancy among white Americans decreased by …
As per a safety communication email dated May 19, 2021, the U.S. Food and Drug Administration (FDA) is reminding the public and health care providers that results from currently authorized SARS-CoV-2 antibody tests should not be used to evaluate a person’s level of immunity or protection from COVID-19 at any time, and especially after the …